Cetuximab Therapeutic Drug Monitoring in Squamous Cell Carcinoma Head and Neck Cancer Patients: Determination of the Predictive Value Exposure Levels Through a Single Arm Multicentric Study

NCT04218136 · clinicaltrials.gov ↗

UNKNOWN

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: Blood samples

Sponsor

Assistance Publique Hopitaux De Marseille